Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 2024International Journal of Molecular SciencesOpen Access

Prognostic Value of HHLA2 in Patients with Solid Tumors: A Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAgnieszka KulaMedical University of SilesiaMDMiriam DawidowiczMedical University of SilesiaSMSylwia MielcarskaMedical University of Silesia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kula et al. (2024) studied this question.

synapsesocial.com/papers/68e6d6d2b6db643587653e60https://doi.org/10.3390/ijms25094760
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune Checkpoint Inhibitors in Cancer Therapy2022 · 1,371 citations
  2. 2HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L12019 · 126 citations
  3. 3Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors2020 · 436 citations
  4. 4High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma2022 · 9 citations
  5. 5B7-H7 is a prognostic biomarker in epithelial ovarian cancer2020 · 8 citations